Boulder, CO, United States of America

Liya Liang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Celyntra Therapeutics Sa. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liya Liang. Retrieved from https://idiyas.com/inventor/liya-liang-ds8l74p3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liya Liang - Innovator in Genome Editing

Introduction

Liya Liang is a prominent inventor based in Boulder, CO (US). She has made significant contributions to the field of genome editing, showcasing her expertise through her innovative patent.

Latest Patents

Liya Liang holds a patent titled "Constructs and uses thereof for efficient and specific genome editing." This patent includes embodiments that disclose novel nucleic acid-guided nucleases, novel guide nucleic acids, and targetable nuclease systems. The methods described in her patent can be utilized for editing the genomes of humans and other species. Her work encompasses advanced techniques such as recursive genetic engineering and trackable genetic engineering methods.

Career Highlights

Liya Liang has established herself as a key figure in the biotechnology sector. She is currently associated with Celyntra Therapeutics, where she applies her knowledge and skills to further advancements in genetic engineering.

Collaborations

Liya collaborates with talented individuals in her field, including Jamie Kershner and Rongming Liu. Their combined expertise fosters an environment of innovation and progress in genome editing technologies.

Conclusion

Liya Liang's contributions to genome editing through her patent and work at Celyntra Therapeutics highlight her role as a leading inventor in the biotechnology industry. Her innovative approaches are paving the way for future advancements in genetic engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…